Glioblastoma Market Snapshot: Two Approvals In 2024 And A Rich Pipeline

 
• By David Wild

Glioblastoma carries a grim prognosis. The biopharma industry is trying to improve patient outcomes, with 120 drugs in the pipeline and two anticipated approvals this year.

Soft and blurry image:Medical image MRI Brain showing There is diameter cystic mass or tumor at Left frontal lobe Glioblastoma at Lt frontal lobe with metastasis, brain metastases.
Biopharma Investments Offer Hope For Glioblastoma Patients • Source: Shutterstock

More from Market Intelligence

More from In Vivo